Tuesday, October 30, 2018

Grünenthal Agrees US$ 922 m Deal With AstraZeneca for Nexium and Vimovo

AACHEN, Germany, October 30, 2018 /PRNewswire/ -- Biggest single investment in Grünenthal's history that will significantly strengthen the company's leading position in pain management Gastroprotective therapies to address a high unmet medical need[1] in pain patients on...

from PR Newswire: //https://ift.tt/2yJDsf0

No comments:

Post a Comment